
ACN · NYSE
Consensus is Buy, with all 21 tracked analysts supporting that rating. The only supplied target statistic is a $180 mean; low and high targets are unavailable, so target clustering and the width of the range cannot be assessed. The evidence does not identify the most bullish or least bullish analyst, nor does it provide any analyst target revisions during the past week. Consequently, the substantive disagreement behind the target spread cannot be established. The available research instead frames the key debate around relative growth: The Motley Fool argues that Microsoft’s revenue profile has been consistently stronger and faster-growing than Accenture’s, while the company’s historical revenue and net-income increases provide the principal counterpoint.